fda glp-1 compounding warning letters september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading FDA Issues Warning Letters to

Angellee J, Novalinda Ginting C, Chiuman L, Halim B, editors

Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer

L-Carnitine 1000 78,200 Towards fat burning and fitness Effervescent tablet In Coffee, Colla flavors Out of stock General Information About This Product L-carnitine is chemically an amino acid and is produced in the body from proteins

A cancer patient can experience a variety of symptoms, not limited to cough, diarrhoea, fatigue, fever, loss of appetite, shortness of breath, nausea, weakness, and weight loss [280, 281]

Multi-omics investigation of Porphyromonas gingivalis exacerbating acute kidney injury through the gut-kidney axis